Yüklüyor......
Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
OBJECTIVE: To investigate the efficacy and safety of belimumab, a human immunoglobulin monoclonal antibody against B lymphocyte stimulator, in a subset of patients with systemic lupus erythematosus (SLE) who were hypocomplementemic (C3 <90 mg/dl and/or C4 <10 mg/dl) and anti–double‐stranded DN...
Kaydedildi:
| Yayımlandı: | Arthritis Rheumatol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6099508/ https://ncbi.nlm.nih.gov/pubmed/29671280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40511 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|